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Available online 29 January 2013Abstract Administration of fibroblastic cells derived from a number of tissues (collectively called “mesenchymal stem cells”)
has been suggested to be beneficial for renal repair and mortality reduction in renal ischemia–reperfusion injury (IRI), but the
underlying mechanism is not fully understood. In the present study, our objective was to investigate the involvement of
macrophages in the therapeutic effect of human umbilical cord-derived stromal cells (hUCSCs) on renal IRI. Twenty-four hours
after reperfusion, hUCSCs were injected intravenously and resulted in significant improvements in renal function, with a lower
tubular injury score together with more proliferative and fewer apoptotic tubular cells in kidney tissue. Moreover, hUCSCs
reduced the infiltration of macrophages into renal interstitium especially at 5 days post-reperfusion, while the proportion
of anti-inflammatory M2 macrophages was markedly increased. HUCSCs also alleviated the local inflammatory response
in kidneys. The absence of macrophages during the early phase of reperfusion enhanced the therapeutic effect of hUCSCs,
whereas macrophage depletion during the late repair phase eliminated the renoprotective role of hUCSCs. In vitro,
macrophages cocultured with hUCSCs were switched to the alternatively activated M2 phenotype. Our data indicate that
hUCSCs are capable of promoting the M2 polarization of macrophages at injury sites, suggesting a new mechanism for
hUCSC-mediated protection in renal IRI.
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Acute kidney injury (AKI), which is characterized by impaired
renal function, results in a major clinical problem especially in
critically ill patients admitted to the intensive care unit.
Considering the poor outcomes and high incidence of AKI,
early diagnosis and the development of effective therapeutic
406 W. Li et al.strategies are urgently needed. Renal ischemia–reperfusion
injury (IRI) is a major cause of AKI in both native and
transplanted kidneys, and is associated with a high level of
mortality and morbidity (Bonventre and Yang, 2011). However,
therapeutic regimens which could completely ameliorate injury
after ischemia and reperfusion are still unavailable. Adminis-
tration of a variety of fibroblastic cells (often called “mesen-
chymal stem cells”) has been suggested to be an effective
treatment to promote renal repair after IRI (Tögel et al., 2005),
but the mechanism involved has not been clearly defined.
There is increasing evidence to suggest that a variety
of fibroblastic cells display capabilities of homing to injury
sites and exerting their profound immunomodulatory role by
regulating both innate and adaptive immune cells (Choi et al.,
2012; Nauta and Fibbe, 2007). Among these cells, macro-
phages have recently been demonstrated to play a potent role
in the pathogenesis and progression of renal IRI (Jo et al., 2006;
Vinuesa et al., 2008). Recently, increasing numbers of studies
have favored the immunomodulatory effects of fibroblastic
cells, which were derived from different tissue sources, on
macrophages as a critical mechanism in the amelioration of
inflammation-related diseases, such as sepsis, wound healing
and acute myocardial infarction (Németh et al., 2009; Zhang
et al., 2010; Dayan et al., 2011). However, the interactions
between human umbilical cord-derived stromal cells (hUCSCs)
and macrophages in the repair progress of renal IRI, especially
whether hUCSCs can induce the polarization ofmacrophages in
kidney tissues, are poorly understood.
Macrophages may play diverse roles in both the injury and
repair phase of diseases (Ricardo et al., 2008). Generally, they
are categorized into two populations defined as classically and
alternatively activatedmacrophages (M1 and M2, respectively)
(Sica and Mantovani, 2012). M1macrophages play an important
role in pathogen clearance and produce high levels of pro-
inflammatory cytokines during injury, whereas M2 macro-
phages contribute to tissue homeostasis and secrete mainly
anti-inflammatory cytokines in the repair phase.
In this current study, we tested the hypothesis that
macrophages located in the damaged kidney tissue after
ischemia–reperfusion can be induced towards the M2 pheno-
type by the administration of human umbilical cord-derived
stromal cells, which may provide a novel explanation for the
mechanism underlying the renoprotective role of hUCSCs.Materials and methods
Mice and renal ischemia–reperfusion model
All experiments were performed in accordance with Chinese
legislation regarding experimental animals. Male C57BL/6mice
aged 8–10 weeks were purchased from the Laboratory Animal
Center (Yangzhou University, China). Mice were housed in
individual microisolator cages under specific pathogen-free
conditions, with free access to water and chow. After they
were anesthetized with an intraperitoneal injection of 2.0%
(w/v) pentobarbital sodium at 4.0 ml/kg, mice were subjected
to bilateral flank incisions and both renal pedicles were
clamped for 30 min with microaneurysm clamps. During
ischemia, mice were hydrated with warm saline and body
temperaturewasmaintained at 37 °Cwith a heating pad. After
the clamps were removed, the kidneys were inspected toconfirm restoration of blood flow and the flank incisions were
sutured in two layers. Sham operation was performed in a
similar manner, without clamping the renal pedicles.
Isolation and infusion of hUCSCs
HUCSCs were isolated as previously described (Qiao et al.,
2008), with a minor improvement. Briefly, human umbilical
cords freshly obtained with donor consent were washed
off the cord blood, and the umbilical artery and vein were
removed prior to mincing. After being rinsed in antibiotics for
disinfection, the remaining cord tissue was cut into 1 mm3
pieces and placed directly into culture dishes for 30 min to
improve tissue attachment. After that, the growingmedium of
Dulbecco's modified Eagle's medium with 10% fetal bovine
serum (10% FBS-DMEM; Gibco, Carlsbad, CA) containing penicil-
lin (100 U/ml) and streptomycin (100 μg/ml) was added to the
tissue explants. Once cells reached subconfluence, tissue pieces
were removed and cells adhering to the dishes were digested
and passaged into flasks for further expansion. At 24 h following
reperfusion, 2×106 hUCSCs (passage 4) suspended in 0.2 ml
sterile phosphate buffer solution (PBS) were injected into mice
via the caudal vein. Alternatively, human lung tissue-derived
fibroblast cells (HFLs, 2×106) suspended in 0.2 ml sterile PBS,
or 0.2 ml sterile PBS alone were injected i.v. into mice as
the controls. HFL cells were purchased from the Institute of
Biochemistry and Cell Biology at the Chinese Academy of
Sciences (Shanghai, China) and maintained in 15% FBS-DMEM
(Gibco).
Homing studies
HUCSCs were prelabeled by incubation with the carbocyanine
fluorescent dye CM-Dil (Molecular Probes, Carlsbad, CA) for
30 min and 2×106 cells were infused into animal models at
24 h after reperfusion. Mice were euthanized at 5 days
post-ischemia and the whole kidneys were analyzed by the
Maestro in-vivo imaging system (CRI Inc., Santa Maria, CA).
On the other hand, the tissues of kidney and lung were
cut into 8-μm snap-frozen sections, counterstained with DAPI
staining solution (Beyotime Institute of Biotechnology, Nantong,
China) and visualized using a confocal microscope (Leica TCS
SP5, Heidelberg, Germany).
Assessment of renal function
The concentrations of creatinine (Cr) and Blood urea
nitrogen (BUN) in serum were measured as the marker of
renal function by an automated biochemical analyzer (Olympus,
Tokyo, Japan).
Histology
Kidney tissues were fixed in 4.0% paraformaldehyde, embedded
in paraffin and cut into 4-μm sections, which were stained with
H&E and viewed by light microscopy (Nikon, Kanagawa, Japan).
The degree of tubular damage was scored by calculating the
percentage of tubules in the corticomedullary junction and
outer medulla which exhibited tubular dilation, cell necrosis
and cast deposition as follows: 0, none; 1, ≤10%; 2, 10–25%; 3,
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overlapping high-power fields (HPFs, ×200) per section were
examined.
Immunohistochemistry
Kidney sections were incubated with 3.0% hydrogen peroxide
for 30 min to remove endogenous peroxidase. After antigen
retrieval, the sections were blocked in 5.0% bovine serum
albumin (BSA) for 20 min. They were then incubated with the
diluted primary antibodies at 4 °C overnight: rat anti-mouse
F4/80 (1:100) (clone: BM8; eBioscience, San Diego, CA),
monocyte chemoattractant protein-1 (MCP-1, 1:200) (sc-1784;
Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit
anti-mouse PCNA (1:80) (BS1289; Bioworld, Minneapolis, MN).
After washing, this was followed by a further incubation
with biotin-conjugated secondary antibody for 20 min. The
complex was visualized with 3,3′-diaminobenzidine (DAB) and
counterstained with hematoxylin for microscopic examina-
tion. The numbers of F4/80-, MCP-1- or PCNA-positive cells in
the corticomedullary junction and outer medulla of kidneys
were counted in 10 randomly selected non-overlapping HPFs
(×400).
Detection of apoptosis by TUNEL staining
Apoptotic cells in the kidney tissues were visualized with
TUNEL staining. The procedure was performed using an in situ
cell death detection kit (Boster Bioengineering Co. Ltd.,
Wuhan, China) according to the manufacturer's protocol. The
number of apoptotic cells in the corticomedullary junction
and outer medulla of kidneys was counted in 10 randomly
selected non-overlapping HPFs (×400).
Liposome preparation and in vivo depletion of
macrophages
Clodronate [dichloromethylene bisphosphonate (Cl2MBP)]
liposome (lipo-Cl2MBP) was prepared according to a previ-
ously described method (Rooijen and Sanders, 1994).
Mice were injected with a bolus of 100 μl/10 g body weight
of lipo-Cl2MBP or liposomal vehicle (lipo-PBS) via the
caudal vein. Two days after injection, immunochemistry was
performed to validate the effect of macrophage depletion in
mouse kidney and spleen tissues.
Coculture of macrophages and hUCSCs
RAW 264.7 cells were first inoculated into 6-well flat-bottom
plates at 8×105 cells/well in high-glucose DMEM (Gibco)
supplemented with 10% heat-inactivated FBS (Gibco). After
6 h of incubation, the supernatant was removed and hUCSCs
were added to the same wells at 2×105 cells/well for an
additional incubation of 3 days. For indirect-contact coculture,
0.4-μm pore size transwell inserts (Corning, Lowell, MA) were
used to partition macrophages and hUCSCs. RAW 264.7 cells or
hUCSCs cultured alone were provided as controls. Cells were
collected for gene analysis of inflammatory cytokines at either
5 h (for IL-6 and arginase-1) or 24 h (for IL-1β and IL-10) after
stimulation with lipopolysaccharide (LPS, Sigma, St. Louis,MO), whereas the supernatants were harvested at 3, 7 and 11 h
for further detection of released IL-10 by ELISA. For phenotype
identification by flow cytometry, cells in coculture were
harvested with a cell scraper after 3 days of incubation.Reverse transcription and RT-PCR analysis
After purification, 1 μg total RNA was reverse transcribed in
a 20 μl reaction volume, which was then processed using a
commercial kit for RT-PCR (Thermo Scientific, Rockford, IL)
according to the manufacturer's instructions. For cocultured
cells, expressions of IL-1β, IL-6, arginase-1 and IL-10 were
detected by PCR, with GAPDH as the housekeeping gene. For
mouse kidney tissues, IL-1β, IL-6 and IL-10 mRNA normalized
to GAPDH were measured by real-time PCR, which was
performed in a reaction mixture containing 10 μl 2×SYBG
Mix, 0.4 μl 10 μM of each primer, 0.1 μl Taq DNA polymerase
(Invitrogen, Carlsbad, CA) and 1 μl cDNA. Primers for mouse
IL-1β, IL-6, arginase-1, IL-10 and GAPDH were designed using
the Primer Software and produced by Invitrogen company
(Table 1). Real-time PCRwas performed in a reactionmixture,
containing 10 μl 2×SYBG Mix (Invitrogen), 0.4 μl 10 μM of
each primer, 0.1 μl Taq DNA polymerase (Invitrogen) and 1 μl
cDNA. All reactions were performed in triplicate on a CFX-96
(Bio-Rad, Hercules, CA) according to the manufacturer's
instructions.Measurement of IL-10 secretion by ELISA
The concentration of the cytokine IL-10 was measured in
the supernatant of macrophages cocultured with hUCSCs
or cultured alone, using a mouse-specific ELISA kit (ExCell
Biology, Shanghai, China) following the manufacturer's proto-
col. The detection limit was 7.0 pg/ml.Flow cytometry
Kidney tissue was minced, incubated with 0.3% collagenase IV
(Sigma), ground gently, and filtered through a 40-μm cell
strainer prewetted with PBS. After washing, the pellet was
incubated with ACK (160 mM NH4Cl, 10 mM KHCO3 and 0.1 mM
EDTA, pH 7.4) to remove erythrocytes and resuspended in
PBS for flow cytometric detection on a FACSCalibur (BD
Biosciences, Sparks, MD). In brief, kidney cells were first
incubated with PE-conjugated anti-CD11b (1:100) (clone:
M1/70; eBioscience) and FITC-conjugated anti-CD206 (1:100)
(MR5D3; Santa Cruz Biotechnology) for 30 min at 4 °C in
the dark. The labeled cells were thenwashed and resuspended
in PBS for analysis. As negative controls, isotype-matched
antibodies with the corresponding fluorescent labeling were
used in our study. Cells in the coculture experiment were also
analyzed according to the same protocol.Statistical analysis
Data are expressed as mean±SEM. Statistics analysis was
performed by the non-parametric Mann–Whitney U test
using SPSS 16.0 software. Statistical significant level was
defined as Pb0.05.
Table 1 Primer sequences for the amplification of target genes.
Genes Accession number Primer sequence (5′–3′) Product size (bp) Annealing temperature (°C)
IL-1β NC_000068 For: 5′-CTTCCTTGTGCAAGTGTCTG-3′ 212 58
Rev: 5′-GCCTGAAGCTCTTGTTGATG-3′
IL-6 NC_000071 For: 5′-GGAGACTTCACAGAGGATAC-3′ 279 52
Rev: 5′-CTCCAGGTAGCTATGGTACT-3′
Arginase-1 NC_000076 For: 5′-CCAGATGTACCAGGATTCTC-3′ 191 56
Rev: 5′-AGCAGGTAGCTGAAGGTCTC-3′
IL-10 NC_000067 For: 5′-CTGAGGCGCTGTCATCGATT-3′ 106 64
Rev: 5′-TGGCCTTGTAGACACCTTGG-3′
GAPDH NC_000072 For: 5′-AAGGTCGGTGTGAACGGATT-3′ 162 62
Rev: 5′-CATTCTCGGCCTTGACTGTG-3′
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HUCSCs preserve renal function and morphology in
mice with renal IRI
Twenty-four hours after reperfusion, 2×106 hUCSCs were
injected into mice with renal IRI. Confocal microscopy showedFigure 1 Tracking of hUCSCs in vivo and effect of hUCSC admini
after reperfusion, 2×106 hUCSCs were administered intravenously in
observed. (A): Confocal images of hUCSCs prelabeled with CM-Dil (r
The nuclei were visualized by DAPI staining (blue) (magnification, ×
injured kidney at 5 days after reperfusion. Three animals were analyz
reperfusion in mice with sham-, PBS-, hUCSC- or HFL-treatment (n=5
reperfusion in mice with sham-, PBS-, hUCSC- or HFL-treatment (n
with PBS group; ns: no significance).that hUCSCs prelabeled with the red fluorescent dye CM-Dil
were localized in the lung and kidney tissues at 5 days after
reperfusion (Fig. 1A). An in vivo imaging study also showed the
homing of large numbers of hUCSCs into the impaired kidney
(Fig. 1B). The level of serum Cr and BUN was markedly
increased at 1 day post-ischemia and gradually reduced from
3 days after reperfusion in IRI mice given PBS (Figs. 1C, D).stration on renal function after reperfusion. Twenty-four hours
to mice with renal IRI by caudal vein and renal function was daily
ed) in the lung and impaired kidney at 5 days after reperfusion.
200). (B): In-vivo imaging of CM-Dil-hUCSC location (red) in the
ed. (C): Quantification of serum Cr at different time points after
). (D): Quantification of serum BUN at different time points after
=5). (#Pb0.01: compared with sham group; ⁎Pb0.01: compared
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serum Cr and BUN levels than PBS controls, and there was
no statistical significance in the levels of Cr and BUN between
the groups treated with PBS and HFL (Figs. 1C, D).
Renal histology of IRI mice given PBS showed severe
impairments, including necrosis and loss of tubular epithelial
cells, dilation of tubular lumens, formation of casts, and
infiltration of inflammatory cells (Fig. 2A). The tubular injury
score peaked at 1 day after reperfusion and remained high
during the following course (Fig. 2B). By contrast, hUCSC
treatment significantly attenuated tubular impairments and
inflammation in kidney tissues (Fig. 2A) and tubular injury
score in hUCSC-treated mice was markedly reduced at 3, 5, 7
and 10 days post-injury (Fig. 2B). However, treatment withFigure 2 Effect of hUCSC administration on renal histology afte
2×106 hUCSCs were administered intravenously into mice with rena
images of H&E-stained kidney sections from sham-, PBS-, hUCSC-
(magnification, ×200). (B): Tubular injury score of the injured kidne
HFL-treatment (n=5). (# Pb0.01: compared with sham group; *Pb0.HFL did not result in any improved amelioration of the renal
injury (Fig. 2A) and showed no statistical significance in
the level of tubular injury score compared with PBS group
(Fig. 2B).HUCSCs accelerate proliferation of tubular cells and
protect tubular cells from apoptosis
Kidney tissues from PBS-treated IRI mice showed a slight
increase in the number of PCNA-positive cells, which peaked
at 3 days after reperfusion (Figs. 3A, B). After infusion of
hUCSCs, the number of PCNA-positive cells increased signifi-
cantly at 3 days after reperfusion and remained high duringr ischemia–reperfusion. Twenty-four hours after reperfusion,
l IRI and renal histology was daily observed. (A): Representative
or HFL-treated mice at different time points after reperfusion
ys at different time points after reperfusion with PBS, hUCSC- or
05, **Pb0.01: compared with PBS group; ns: no significance).
410 W. Li et al.the following course. Treatment with HFL did not lead to the
promotion of proliferation in tubular epithelial cells, and there
was no statistical significance in the number of PCNA-positive
cells between PBS and HFL treated groups (Figs. 3A, B).
On the other hand, a marked increase in the number
of TUNEL-positive cells was detected in IRI mice given PBS
which peaked at 1 day after reperfusion, and hUCSC treatment
significantly reduced the number of apoptotic tubular cells
at 3, 5 and 10 days post-reperfusion (Figs. 3A, C). Moreover,
animals treated with HFL showed no statistical significance in
the number of TUNEL-positive tubular cells compared with PBS
group (Figs. 3A, C).
HUCSC therapy reduces the infiltration of F4/80-
positive macrophages in the injured kidney
Immunochemistry showed that F4/80-positive macrophages
were mainly located in the interstitial area of kidney sections
(Fig. 4A). The number of F4/80-positive macrophages in IRI
mice given PBS significantly increased throughout the obser-
vation period and peaked at 5 days after reperfusion (Fig. 4E).
However when infused with hUCSCs, the number of F4/80-
positivemacrophages wasmarkedly reduced at 5, 7 and 10 days
after reperfusion (Figs. 4B, E). The role of MCP-1, a majorFigure 3 Effect of hUCSC administration on the proliferation and a
of PCNA and TUNEL immunostaining in the injured kidneys at
(magnification, ×400). (B): Quantification of PCNA-positive tubular
after reperfusion with PBS-, hUCSC- or HFL-treatment (n=5). (C): Q
kidney sections at different time points after reperfusion with PBS-,
group; ⁎Pb0.01: compared with PBS group; ns: no significance).macrophage chemokine, in the infiltration of macrophages was
taken into account and investigated in the kidney sections
treated with or without hUCSCs. Immunostaining of MCP-1 in
the tubular epithelial cells (Fig. 4C) showed that the number of
MCP-1-positive cells significantly increased in PBS-treated IRI
mice, peaking at 1 day after reperfusion and lasting through the
following course (Fig. 4F). After hUCSC infusion, the number of
MCP-1-positive cells was markedly reduced at 3, 5 and 7 days
(Figs. 4D, F).Depletion of macrophages during injury accelerates
the therapeutic effect of hUCSCs
Immunostaining showed that macrophages were detected in
the spleen and kidney at 2 days after lipo-PBS infusion, but
that infiltrated macrophages were significantly depleted at
2 days after lipo-Cl2MBP injection (Fig. 5A). Five days after
reperfusion, severe histopathology was observed in control
mice given PBS, and this impairment was largely reversed by
hUCSC infusion (Fig. 5B). In mice treated with lipo-Cl2MBP 24 h
before surgery, hUCSC administration provided a further
protective effect on renal damage with the best preserved
tubular integrity (Figs. 5B, C).poptosis of tubular epithelium cells. (A): Representative images
5 days after reperfusion treated with PBS, hUCSCs or HFL
epithelium cells in the kidney sections at different time points
uantification of TUNEL-positive tubular epithelium cells in the
hUCSC- or HFL-treatment (n=5). (#Pb0.01: compared with sham
Figure 4 Effect of hUCSC administration onmacrophage recruitment and expression of MCP-1 in the kidney after IRI. (A): Representative
images of interstitial macrophages labeled with F4/80 in the kidney of mice treated with PBS at 5 days after reperfusion.
(B): Representative images of interstitial macrophages labeled with F4/80 in the kidney of mice treated with hUCSCs at 5 days after
reperfusion. (C): Representative images of MCP-1-positive tubular epithelial cells in the kidneys of mice treated with PBS at 5 days
after reperfusion. (D): Representative images of MCP-1-positive tubular epithelial cells in the kidneys of mice treated with hUCSCs
at 5 days after reperfusion (magnification, ×200 and ×400). (E): Quantification of F4/80-positive macrophages in the kidney
sections at different time points after reperfusion with PBS or hUCSC treatment (n=5). (F): Quantification of MCP-1-positive
tubular epithelial cells in the kidney sections at different time points after reperfusion with PBS or hUCSC treatment (n=5).
(#Pb0.01: compared with sham group; ⁎Pb0.05, ⁎⁎Pb0.01: compared with PBS group).
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the therapeutic effect of hUCSCs
As the behavior of macrophages is affected by the inflamma-
tory microenvironment at different stages after reperfusion,
the possible role of macrophages in the therapeutic action
of hUCSCs during the late repair phase was also investi-
gated. In mice treated with lipo-Cl2MBP 24 h after surgery,
depletion of macrophages eliminated the preservation
of renal integrity by hUCSCs at 5 days following reperfusion,which led to a failure in the repair progress following renal
injury (Figs. 5B, C).HUCSCs modulate the gene expression of cytokines
in RAW 264.7 cells
RT-PCR showed that the expression of IL-1β and IL-6 in RAW
264.7 cells cocultured with hUCSCs was markedly inhibited,
whereas the expression of arginase-1 and IL-10 was enhanced
Figure 5 Renal histology after macrophage depletion in hUCSC-treatedmice with IRI. (A): Immunohistochemical images of F4/80-positive
macrophages in the spleen and kidney tissues at 2 days after lipo-PBS or lipo-Cl2MBP injection (magnification: spleen, ×200; kidney, ×400).
(B): Representative images of H&E-stained kidney sections at 5 days after reperfusion from mice treated with PBS or hUCSCs and
hUCSC-treated mice injected with lipo-Cl2MBP 24 h before or after surgery (magnification, ×200 and ×400). (C): Quantification of tubular
injury score in the kidney sections at 5 days after reperfusion from mice with distinct treatments (n=5). (⁎Pb0.05; ⁎⁎Pb0.01). LC, liposome
clodronate (lipo-Cl2MBP).
412 W. Li et al.following stimulation with LPS (Fig. 6A). Due to the genus
specific primers of mouse-origin, no expression of cytokines
was detected in hUCSCs which were cultured alone. In
addition, the cytokine profile of RAW 264.7 cells cocultured
with hUCSCs in a transwell system was similar to that of RAW
264.7 cells cocultured in direct contact with hUCSCs (Fig. 6A).
This data suggest that both the direct contact and paracrine
activity of hUCSCs contribute to alterations in the cytokine
profile of macrophages in vitro.
ELISA analysis demonstrated that the level of IL-10 highly
increased in the supernatant of RAW 264.7 cells at 7 h after LPS
addition and persisted for at least 11 h (Fig. 6B). However, IL-10
level in the supernatant of RAW 264.7 cells cocultured with
hUCSCs was found to be significantly higher than that of RAW
264.7 cells cultured alone at 7 and 11 h after LPS stimulation
(Fig. 6B).
HUCSCs alleviate the local inflammatory response in
the injured kidneys
Compared with PBS controls, hUCSC therapy resulted in a
significant reduction in the mRNA expression of IL-1β and IL-6in the impaired kidneys. By contrast, the gene expression
of IL-10 was greatly increased by hUCSC treatment (Fig. 6C).
In mice withmacrophage absence during injury, the expression
of cytokines was comparable with mice treated with hUCSCs
alone. On the other hand, mice with macrophage absence
during repair were characterized by a high expression of IL-1β
and IL-6, and a low expression of IL-10 after hUCSC therapy,
with no significant difference from PBS controls (Fig. 6C).HUCSCs switch macrophages to the M2 phenotype in
vitro or in vivo
RAW 264.7 cells cocultured with hUCSCs in a direct contact
manner or in a transwell system exhibited a significant
increase in the percentage of CD206+ cells among CD11b+
macrophages, compared with RAW 264.7 cells cultured
alone (Fig. 7A). In vivo, we also demonstrated that hUCSCs
led to a significant increase in the percentage of CD206+ and
CD11b+ macrophages among the cells of impaired kidneys
at 5 days after reperfusion, compared with PBS controls
(Fig. 7B).
413Macrophages are involved in the protective role of human umbilical cord-derived stromal cellsDiscussionIn recent years, stromal cells derived from bone marrow,
adipose tissue, or fetal membrane have been demonstrated to
be beneficial for recovery from acute kidney injury (Morigi
et al., 2008; Feng et al., 2010; Tsuda et al., 2010). Previously,
we found that bone marrow stromal cells (BMSCs) ameliorated
acute renal failure in a rat model induced by glycerol
injection (Qian et al., 2008). However, human umbilical
cord has recently become an attractive source of stromal
cells, since a larger number of cells can be easily obtained
from it without raising any ethical objections (Chao et al.,
2008). A previous study reported that hUCSCs are morpho-
logically and immunophenotypically similar to BMSCs, but
are more committed to matrix remodeling and angiogen-
esis (Panepucci et al., 2004). Thus, hUCSCs may be an ideal
source of stromal cells for cell-based therapies and we haveFigure 6 Cytokine expression profiles of macrophages with hUCSC
IL-10 expression in RAW 264.7 cells after coculture either in direc
LPS stimulation. (B): ELISA analysis of the anti-inflammatory cytok
The results were representative of three independent experiments
expression in the kidney tissues collected from mice at 5 days pos
representative of three independent experiments (mean±SEM). (⁎Pestablished a method to isolate stromal cells from human
umbilical cord (Qiao et al., 2008). In this current study, we
observed that exogenous hUCSCs could home to and localize at
the site of lung and injured kidney and play a beneficial role
in renal functional and histological improvements, which is
in agreement with our previous findings (Qian et al., 2008;
Cao et al., 2010; Chen et al., 2011).
Ischemia–reperfusion injury results in a characteristic
appearance of necrosis/apoptosis of tubular epithelial cells in
the kidneys (Kennedy and Erlich, 2008). In this study, we found
that hUCSCs promoted the proliferation of tubular epithelial
cells, whereas they inhibited the apoptosis of tubular epithelial
cells. This demonstrates that hUCSCs can ameliorate mouse
renal IRI by improving tissue regeneration and reducing tissue
necrosis in the injured kidneys, which may therefore be
responsible for the renoprotective effect of hUCSCs. However,
the mechanisms underlying these roles remain incompletely
understood.treatment. (A): RT-PCR analysis of IL-1β, IL-6, arginase-1 and
t or in indirect contact with hUCSCs for 3 days in response to
ine IL-10 secreted by RAW 264.7 cells cocultured with hUCSCs.
(mean±SEM). (C): Real-time RT-PCR analysis of cytokine mRNA
t-reperfusion following different treatments. The results were
b0.05). TW, transwell; LC, liposome clodronate (lipo-Cl2MBP).
Figure 7 Proportion of CD206-positive macrophages with hUCSC treatment. (A): Flow cytometric analysis for the proportion of CD206-
positive cells among CD11b-labeled RAW 264.7 cells after being cocultured with hUCSCs for 3 days either in direct or in indirect contact
compared with RAW 264.7 cells cultured alone. (B): Five days after reperfusion, cells collected from kidney tissues were immunostained
with PE-CD11b and FITC-CD206 antibodies and subjected to flow cytometry analysis. TW, transwell.
414 W. Li et al.Previously, we demonstrated that injured kidney tissues
can induce bone marrow stromal cells to differentiate into
renal tubular epithelial-like cells in vitro and in vivo (Qian
et al., 2008). However, another work reported that the
beneficial effects of BMSCs are primarily mediated by complex
paracrine actions, but not by their differentiation into target
cells (Tögel et al., 2005). Recently, there is increasing evidence
to indicate that immunomodulation does play a critical role in
the therapeutic effect of multipotential stromal cells, since
tissue injury is generally inflammation-related (Semedo et al.,
2009; Aronin and Tuan, 2010; Jang et al., 2009). In particular,
many studies have focused on themodulatory effect of stromal
cells on macrophages (Kim and Hematti, 2009; Chen et al.,
2008; Maggini et al., 2010). One study demonstrated that
BMSCs can beneficially modulate the response of the host
immune system to sepsis and interact with both circulating and
tissue macrophages (Németh et al., 2009). Another report
indicated that human gingiva-derived stromal cells can induce
M2 polarization of macrophages, which may contribute to a
marked acceleration of cutaneous wound healing (Zhang et al.,
2010). In the present study, macrophage recruitment occurred
rapidly in the interstitial area of injured kidneys and peaked at
5 days after reperfusion, which was reduced significantly
following hUCSC treatment. Furthermore, we sought to find
out the role of chemokine MCP-1 in macrophage recruitmenteffected by hUCSCs. Our results showed that the number
of MCP-1-positive tubular epithelial cells was also markedly
reduced by hUCSC administration. Thus, these findings provide
the first evidence that hUCSCs are capable of reducing
macrophage infiltration in the injured kidneys, at least in part
by downregulating the expression of MCP-1 in tubular epithelial
cells.
In vivo, we performedmacrophage depletion by lipo-Cl2MBP
and chose to deplete macrophages at different stages of
reperfusion, to find out whether they have distinct functions
which would result in conflicting conclusions (Duffield et al.,
2005). Our results show that macrophage abolishment during
the early injury phase promotes the ameliorating effect of
hUCSCs on renal IRI. This finding is in agreement with current
evidence demonstrating the contribution of macrophages
to the initiation of renal damage (Jo et al., 2006; Day et al.,
2005). Conversely, macrophage depletion during the late
repair phase led to a loss of the therapeutic effect of hUCSCs
on kidney damage. One group reported that macrophages are
involved in the repair phase and are beneficial for kidney repair
after IRI (Vinuesa et al., 2008). Here, we provide the first
evidence that macrophage infiltration during recovery may be
essential for the protective role of hUCSCs in renal IRI.
In a coculture experiment, we found that hUCSCs
suppressed the transcription of IL-1β and IL-6 mRNA in
415Macrophages are involved in the protective role of human umbilical cord-derived stromal cellsmacrophages, whereas aginase-1 and IL-10 were upregulated.
These findings suggest that hUCSCs can switch the cytokine
expression of macrophages into an anti-inflammatory phe-
notype, characteristic of M2 macrophages, in vitro. In vivo,
hUCSC-treated kidneys also showed a significant suppression of
the expression of IL-1β and IL-6, and an upregulation of IL-10.
Thus, our observations indicate that hUCSCs are capable of
modulating the cytokine expression ofmacrophages, whichmay
contribute to the resolution of inflammation at injury sites in
renal IRI. On the other hand, flow cytometric analysis showed
increased CD206 expression on the surface of macrophages
cocultured with hUCSCs, and that the proportion of CD206+
macrophages was upregulated during recovery following hUCSC
treatment in the kidney tissues. Taken together, our findings
suggest that hUCSCs elicit the M2 polarization of macrophages,
which may result in an accelerated recovery of renal IRI.
Conclusions
In conclusion, we demonstrated in this study that hUCSCs can
migrate into injured kidneys, and improve renal function
and morphology in an established mouse model of renal IRI.
Our findings indicate, for the first time to our knowledge, that
hUCSCs can reduce the infiltration of macrophages into injured
kidneys, but also increase the proportion of M2-like macro-
phages during repair, which is beneficial for an accelerated
recovery. These findings suggest that hUCSCs are effective
in ameliorating mouse renal IRI possibly by transforming
the infiltrated macrophages into the M2 phenotype, which
may provide new insight into the mechanisms underlying the
therapeutic effect of hUCSCs and supply a foundation assistant
for therapeutic strategies.
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